Impact of co-occurring psychiatric disorders on retention in a methadone maintenance program: An 18-month follow-up study

International Journal of Environmental Research and Public Health

Volumn 6, Issue 11, 2009, Pages 2822-2832

  Astals, Mònica ^a   Díaz, Laura ^a   Domingo Salvany, Antònia ^a   Martín Santos, Rocío ^a   Bulbena, Antoni ^a,b   Torrens, Marta ^a,b  

^a HOSPITAL DEL MAR   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Co occurring psychiatric disorders; Incidence; Methadone; Retention

Indexed keywords

METHADONE; OPIATE;

ADULT; ANTISOCIAL BEHAVIOR; ARTICLE; BORDERLINE STATE; COMORBIDITY; DRUG RETENTION; FEMALE; FOLLOW UP; HEALTH PROGRAM; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MENTAL DISEASE; METHADONE TREATMENT; MORBIDITY; OPIATE ADDICTION; PSYCHOLOGIC ASSESSMENT; TREATMENT DURATION;

EID: 73449100140     PISSN: None     EISSN: 16604601     Source Type: Journal    
DOI: 10.3390/ijerph6112822     Document Type: Article

References (28)

1. Marsch, L.A. The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis. Addiction 1998, 93, 515-532.
2. Amato, L.; Davoli, M.; Perucci, C.A.; Ferri, M.; Faggiano, F.; Mattick, R.P. An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research. J. Subst. Abuse Treat. 2005, 28, 321-329.
3. Brugal, M.T.; Domingo-Salvany, A.; Puig, R.; Barrio, G.; Garcia, D.O.; de la Fuente L. Evaluating the impact of methadone maintenance programmes on mortality due to overdose and aids in a cohort of heroin users in Spain. Addiction 2005, 100, 981-989.
4. Torrens, M.; San, L.; Martinez, A.; Castillo, C.; Domingo-Salvany, A.; Alonso, J. Use of the Nottingham Health Profile for measuring health status of patients in methadone maintenance treatment. Addiction 1997, 92, 707-716.
5. Torrens, M.; Domingo-Salvany, A.; Alonso, J.; Castillo, C.; San, L. Methadone and quality of life. Lancet 1999, 353, 1101.
6. Friedmann, P.D.; Lemon, S.C.; Anderson, B.J.; Stein, M.D. Predictors of follow-up health status in the Drug Abuse Treatment Outcome Study (DATOS). Drug Alcohol Depend. 2003, 69, 243-251.
7. Simpson, D.; Sells, S. Effectiveness of treatment for drug abuse: an overwiew of the DARP research program. Adv. Alcohol Subst. Abuse 1982, 2, 7-29.
8. Chatham, L.R.; Hiller, M.L.; Rowan-Szal, G.A.; Joe, G.W.; Simpson, D.D. Gender differences at admission and follow-up in a sample of methadone maintenance clients. Subst. Use Misuse 1999, 34, 1137-1165.
9. Gossop, M.; Stewart, D.; Browne, N.; Marsden, J. Methadone treatment for opiate dependent patients in general practice and specialist clinic settings: Outcomes at 2-year follow-up. J. Subst. Abuse Treat. 2003, 24, 313-321.
10. Peles, E.; Schreiber, S.; Adelson, M. Factors predicting retention in treatment: 10-year experience of a methadone maintenance treatment (MMT) clinic in Israel. Drug Alcohol Depend. 2006, 82, 211-217.
11. Gelkopf, M.; Weizman, T.; Melamed, Y.; Adelson, M.; Bleich, A. Does psychiatric comorbidity affect drug abuse treatment outcome? A prospective assessment of drug abuse, treatment tenure and infectious diseases in an Israeli methadone maintenance clinic. Isr. J. Psychiatry Relat. Sci. 2006, 43, 126-136.
12. Teesson, M.; Ross, J.; Darke, S.; Lynskey, M.; Ali, R.; Ritter, A.; Cooke, R. One year outcomes for heroin dependence: findings from the Australian Treatment Outcome Study (ATOS). Drug Alcohol Depend. 2006, 83, 174-180.
13. Cacciola, J.S.; Alterman, A.I.; Rutherford, M.J.; McKay, J.R.; Mulvaney, F.D. The relationship of psychiatric comorbidity to treatment outcomes in methadone maintained patients. Drug Alcohol Depend. 2001, 61, 271-280.
14. Farre, M.; Mas, A.; Torrens, M.; Moreno, V.; Cami, J. Retention rate and illicit opioid use during methadone maintenance interventions: a meta-analysis. Drug Alcohol Depend. 2002, 65, 283-290.
15. Broome, K.M.; Flynnn, P.M.; Simpson, D.D. Psychiatric comorbidity measures as predictors of retention in drug abuse treatment programs. Health Serv. Res. 1999, 34, 791-806.
16. Morral, A.R.; Belding, M.A.; Iguchi, M.Y. Identifying methadone maintenance clients at risk for poor treatment response: pretreatment and early progress indicators. Drug Alcohol Depend. 1999, 55, 25-33.
17. Torrens, M.; Castillo, C.; Perez-Sola, V. Retention in a low-threshold methadone maintenance program. Drug Alcohol Depend. 1996, 41, 55-59.
18. Verthein, U.; Degkwitz, P.; Haasen, C.; Krausz, M. Significance of comorbidity for the long-term course of opiate dependence. Eur. Addict. Res. 2005, 11, 15-21.
19. Schuckit, M.A. Comorbidity between substance use disorders and psychiatric conditions. Addiction 2006, 101, 76-88.
20. Nunes, E.V.; Rounsaville, B.J. Comorbidity of substance use with depression and other mental disorders: from Diagnostic and Statistical Manual of Mental Disorders, fourth edition (DSM-IV) to DSM-V. Addiction 2006, 101, 89-96.
21. Astals, M.; Domingo-Salvany, A.; Castillo-Buenaventura, C.; Tato, J.; Vazquez, J.M.; Martin-Santos, R.; Torrens, M. Impact of substance dependence and dual diagnosis on the quality of life of heroin users seeking treatment. Subst. Use Misuse 2008, 43, 612-632.
22. Torrens, M.; Serrano, D.; Astals, M.; Perez-Dominguez, G.; Martin-Santos, R. Diagnosing comorbid psychiatric disorders in substance abusers: validity of the Spanish versions of the Psychiatric Research Interview for Substance and Mental Disorders and the Structured Clinical Interview for DSM-IV. Am. J. Psychiatry 2004, 161, 1231-1237.
23. Hasin, D.; Samet, S.; Nunes, E.; Meydan, J.; Matseoane, K.; Waxman, R. Diagnosis of comorbid psychiatric disorders in substance users assessed with the Psychiatric Research Interview for Substance and Mental Disorders for DSM-IV. Am. J. Psychiatry 2006, 163, 689-696.
24. Grant, B.F.; Goldstein, R.B.; Chou, S.P.; Huang, B.; Stinson, F.S.; Dawson, D.A.; Saha, T.D.; Smith, S.M.; Pulay, A.J.; Pickering, R.P.; Ruan, W.J.; Compton, W.M. Sociodemographic and psychopathologic predictors of first incidence of DSM-IV substance use, mood and anxiety disorders: results from the Wave 2 National Epidemiologic Survey on Alcohol and Related Conditions. Mol. Psychiatry 2008.
25. Verheul, R. Co-morbidity of personality disorders in individuals with substance use disorders. Eur. Psychiatry 2001, 16, 274-282.
26. Darke, S.; Wodak, A.; Hall, W.; Heather, N.; Ward, J. Prevalence and predictors of psychopathology among opioid users. Br. J. Addict. 1992, 87, 771-776.
27. Pitre, U.; Dansereau, D.F.; Joe, G.W. Client education levels and the effectiveness of node-link maps. J. Addict. Dis. 1996, 15, 27-44.
28. Szapocznik, J.; Ladner, R. Factors related to successful retention in methadone maintenance: a review. Int. J. Addict. 1977, 12, 1067-1085.